(19)
(11) EP 0 906 310 A1

(12)

(43) Date of publication:
07.04.1999 Bulletin 1999/14

(21) Application number: 97929769.0

(22) Date of filing: 03.06.1997
(51) International Patent Classification (IPC): 
A61K 31/ 00( . )
A61K 31/ 4427( . )
A61K 31/ 47( . )
A61K 31/ 505( . )
A61K 31/ 529( . )
A61P 3/ 04( . )
A61P 3/ 10( . )
A61P 43/ 00( . )
C07D 409/ 14( . )
C07D 413/ 14( . )
A61K 31/ 44( . )
A61K 31/ 4439( . )
A61K 31/ 4709( . )
A61K 31/ 517( . )
A61P 3/ 00( . )
A61P 3/ 06( . )
A61P 25/ 24( . )
C07D 213/ 40( . )
C07D 413/ 12( . )
(86) International application number:
PCT/US1997/009536
(87) International publication number:
WO 1997/046556 (11.12.1997 Gazette 1998/01)
(84) Designated Contracting States:
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 07.06.1996 US 19960019295P
05.07.1996 GB 19960014191

(71) Applicant: MERCK & CO., INC.
Rahway, New Jersey 07065 (US)

(72) Inventors:
  • BIFTU, Tesfaye
    Rahway, NJ 07065 (US)
  • FENG, Danqing, Dennis
    Rahway, NJ 07065 (US)
  • FISHER, Michael, H.
    Rahway, NJ 07065 (US)
  • KUO, Chan-Hwa
    Rahway, NJ 07065 (US)
  • LIANG, Gui-Bai
    Rahway, NJ 07065 (US)
  • WEBER, Ann, E.
    Rahway, NJ 07065 (US)
  • NAYLOR, Elizabeth, M.
    Rahway, NJ 07065 (US)

(74) Representative: Hiscock, Ian James, et al 
European Patent Department, Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR
Harlow, Essex CM20 2QR (GB)

   


(54) OXADIAZOLE BENZENESULFONAMIDES AS SELECTIVE $g(b) 3? AGONISTS FOR THE TREATMENT OF DIABETES AND OBESITY